Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts

Author： Han W.   Murray-Segal L.   Gershenzon A.   Zhang J.   Hodder A.   Pietersz G.   Mottram P.  

Publisher： Elsevier

ISSN： 0966-3274

Source： Transplant Immunology, Vol.7, Iss.4, 1999-12, pp. : 207-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idarubicin-anti-CD3 reduces vascular disease in mouse cardiac allografts

By Mottram P.L.   Han W.   Murray-Segal L.   Pietersz G.A.   McKenzie I.F.C.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1414-1415

Elsevier

Access to resources Recommend Favorite

Reversal of CTLA4Ig-Mediated Tolerance to Cardiac Allografts by Exogenous Interleukin-2

By Arima T.   Rehman A.   Flye M.W.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1305-1306

Elsevier

Access to resources Recommend Favorite

Effect of Cyclosporine on Chronic Graft Vascular Disease in a Rat Cardiac Isograft Model

By Teranishi K.   Poston R.S.   Tsao P.S.   Asagami T.   Cooke J.P.   Reitz B.A.   Robbins R.C.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1012-1013

Elsevier

Access to resources Recommend Favorite

Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients

By Han W.   Murray-Segal L.   Mottram P.  

Transplant Immunology, Vol. 7, Iss. 1, 1999-03 ,pp. : 37-44

Elsevier

Access to resources Recommend Favorite

The Shift of Th1Th2 Ratios Induced by Portal Venous Administration of UVB-Treated Donor Spleen Cells Prolonged Mouse Cardiac Allografts

By Yu S.   Tu Y.   Flye M.W.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1162-1162

Elsevier

Access to resources Recommend Favorite